BIOCELTIX S.A. ZY -10 (XI3) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-1.93x
BIOCELTIX S.A. ZY -10 (XI3) has a Cash Flow-to-Debt Ratio of -1.93x as of December 2025, meaning its operating cash flow of €-4.54 Million could theoretically repay -2% of its total liabilities (€2.36 Million) in one year. See BIOCELTIX S.A. ZY -10 leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-1.93x
Operating CF / Total Liabilities
Operating Cash Flow
€-4.54 Million
EUR
Total Liabilities
€2.36 Million
EUR
Data as of
Dec 2025
Most recent filing
BIOCELTIX S.A. ZY -10 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for BIOCELTIX S.A. ZY -10 across 5 annual periods. For the full cash flow conversion analysis, see cash flow conversion of BIOCELTIX S.A. ZY -10.
Annual Cash Flow-to-Debt Ratio for BIOCELTIX S.A. ZY -10 (2021–2025)
Year-by-year debt coverage analysis for BIOCELTIX S.A. ZY -10.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.07x | €-11.95 Million | €2.36 Million | ▲ +0.8% |
| 2024 | -5.11x | €-17.57 Million | €3.44 Million | ▲ +21.4% |
| 2023 | -6.50x | €-14.75 Million | €2.27 Million | ▼ -106.6% |
| 2022 | -3.15x | €-7.87 Million | €2.50 Million | ▼ -72.0% |
| 2021 | -1.83x | €-4.02 Million | €2.20 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.